Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
NCT03399175Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2015
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in Vogt-Koyanagi-Harada disease (VKH), sponsored by Universidade de São Paulo. Primary endpoint: Scotopic electroretinogram results at 12 months. Started Mar 2015; status: recruiting.
02
Conditions
Vogt-Koyanagi-Harada disease (VKH)
Beyond the preview
Go deeper on NCT03399175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399175.